Biologics & Biosimilars Advocacy Workshop on Patient Safety: Copenhagen

A recent workshop hosted by the Global Alliance for Patient Access (GAfPA) allowed patient advocates from across Europe’s Nordic region to consider biosimilar policies and discuss a topic of growing international interest: switching from a biologic to a biosimilar medicine. The workshop, held on October 5-6, 2016 in Copenhagen, drew seven different patient advocacy groups from Denmark, Sweden and Iceland.

Read Report

Sign up to receive updates from GAfPA